# AbCellera Biologics Inc.: Form 8-K, filed Nov 28, 2025

- Company: [AbCellera Biologics Inc.](/companies/abcl.md) (CIK 1703057)
- Form: 8-K
- Filed: 2025-11-28
- Accepted by EDGAR: Nov 28, 2025, 14:20 ET
- Period: 2025-11-24
- Accession: 0001703057-25-000032
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1703057/000170305725000032/abcl-20251124.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1703057/000170305725000032/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1703057/000170305725000032/abcl-20251124.htm

Filed Nov 28, 2025.
Source: SEC EDGAR, the filing index for accession 0001703057-25-000032. Last ingested by Listed: Nov 15, 2026, 01:06 ET. No prices; not investment advice.
